15% fall discount applied automatically at checkoutFree USA shipping over $100Free worldwide shipping over $200Credit/debit checkout disabled for updates
Sign in 0
Sale!

Preloaded Autoinjector | 5-Amino-1MQ | 3ml Pen | 50mg/ml

Original price was: $139.99.Current price is: $119.99.

Safety data sheet PL-SDS-002 GHS: not classified as hazardous · Read the SDS · PDF

5-amino-1MQ preloaded pen: 5-amino-1-methylquinolinium iodide, a small-molecule NNMT inhibitor, at 50 mg/mL in bacteriostatic water, 150 mg per 3 mL cartridge. Filled from a lot tested in PrymaLab’s own laboratory. Research use only.

Description

PrymaLab · Research use only

Preloaded Autoinjector | 5-Amino-1MQ | 3ml Pen | 50mg/ml

5-amino-1MQ iodide at 50 mg/mL in bacteriostatic water, 150 mg in a 3 mL pen

5-amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule NNMT inhibitor, not a peptide. In this listing it comes ready-dissolved: a preloaded pen with a 3 mL glass cartridge of the iodide salt in bacteriostatic water at 50 mg/mL, 150 mg per pen, so nothing has to be weighed. Research on 5-amino-1MQ covers enzyme inhibition, fat cell metabolism and diet-induced obesity in mice; none of it used a pre-made solution.

Specifications

Preloaded Autoinjector | 5-Amino-1MQ | 3ml Pen | 50mg/ml at a glance
Property Value
Compound 5-Amino-1MQ 5-Amino-1-methylquinolinium iodide (NNMT inhibitor); small molecule, not a peptide
CAS number 42464-96-0
Molecular formula C10H11IN2
Theoretical mass 286.1 Da
Sequence / structure Quinolinium salt (iodide); the 5-amino-1-methylquinolinium cation is 159.2 Da and is the species observed by ESI-MS.
Contents 5-Amino-1MQ: 150 mg per 3 mL pen (5% w/v)
Form Sterile aqueous solution in bacteriostatic water (0.9% benzyl alcohol), supplied in a 3 mL glass cartridge inside a preloaded autoinjector pen fitted with a needle
Storage, sealed Store at 2–8 °C in the original carton, protected from light
Safety data sheet PL-SDS-002

What is in the pen

The cartridge holds a sterile solution of 5-amino-1-methylquinolinium iodide at 5% w/v, which is 50 mg/mL and 150 mg across 3 mL. The figure is the iodide salt, so in molar terms it is about 175 mM of the active cation, or roughly 0.52 mmol per pen. The solvent is bacteriostatic water with 0.9% benzyl alcohol. The safety data sheet classifies 5-amino-1MQ as harmful if swallowed and as a skin, eye and respiratory irritant, and benzyl alcohol as harmful if swallowed or inhaled, an eye irritant and a skin sensitiser.

Keep the pen at 2 to 8 °C in its carton, out of the light and capped between uses, and never freeze it. Discard it if the solution has frozen or looks cloudy or discoloured. The same salt is sold dry in the 5-amino-1MQ 50 mg vial, and peptide pen vs vial covers the general trade-offs between formats.

What the research covers

NNMT uses SAM to methylate nicotinamide, a precursor of NAD+, and Kraus and colleagues showed in 2014 that its expression rises in the fat and liver of obese and diabetic mice1. Knocking it down in those tissues protected mice against diet-induced obesity, and inhibiting it raised adipose SAM and NAD+1. The knockdown also increased the activity of ODC and SSAT, two enzymes that control polyamine flux1. Small-molecule inhibitors followed. Neelakantan and colleagues reported in 2018 that methylquinoliniums carrying a primary amine, the group that includes 5-amino-1MQ, crossed membranes readily in permeability assays, left related SAM-dependent methyltransferases alone, and were tested in cultured fat cells and in mice made obese on a high-fat diet2. Inside the cultured fat cells, those compounds reduced the enzyme’s product MNA, increased NAD+ and SAM and cut lipid synthesis2. A structurally different inhibitor from another group, JBSNF-000088, lowered body weight and improved glucose tolerance in obese mice but had no such effect in NNMT knockout mice3.

All of this is cell and mouse work, and none of it involved a solution stored in a pen. The references contain no human data on 5-amino-1MQ and nothing on how long it stays stable in water. The 5-amino-1MQ guide covers the literature in full.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. Published certificates are listed on the results page and can be checked by number and key on the verify page. The certificate covers the peptide lot used to fill the pen, not the finished solution. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

What concentration does the pen hold, and on what basis?

50 mg/mL of 5-amino-1-methylquinolinium iodide, 150 mg in the 3 mL cartridge. The figure refers to the iodide salt, as on the vials, and works out to about 175 mM. Each salt unit carries one cation, so that is also the molar concentration of the active ion.

Does the certificate cover the solution?

It covers the 5-amino-1MQ lot used to fill the pen, tested in PrymaLab's own laboratory, and not the finished solution in the cartridge. Published certificates can be checked by number and key on the verify page.

How does the pen compare with the vials?

The vials hold dry salt at −20 °C and let you set the concentration when dissolving it. The pen is a fixed 50 mg/mL solution kept at 2 to 8 °C and never frozen. Neither format has been studied as such; the published work used the compound itself.

Is the pen for human use?

No. It is sold only for laboratory research, has no approval for human or veterinary use from the FDA or any other authority, and must not be given to people or animals.

References

  1. Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-62. DOI · PubMed
  2. Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018;147:141-152. DOI · PubMed
  3. Kannt A, Rajagopal S, Kadnur SV, et al. A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep. 2018;8(1):3660. DOI · PubMed

Research use only

For laboratory research use only. This product is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Other formats of 5-Amino-1MQ

5-Amino-1MQ is also stocked as 5-amino-1MQ 5MG and 5-Amino-1MQ 50mg (60 Capsules). Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats.

Additional information

Safety data sheet PL-SDS-002 · 5-Amino-1MQ

GHS safety data sheet for this product (solution, preloaded autoinjector pen), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Not classified as hazardous Not classified under OSHA HCS 2012 / GHS. No pictogram, signal word or hazard statement is required; handle as a pharmacologically active laboratory chemical.
Composition5-Amino-1MQ (CAS 42464-96-0) · 5% w/v, 150 mg per 3 mL pen
Benzyl alcohol (preservative) (CAS 100-51-6) · 0.9% w/v
Water for injection (CAS 7732-18-5) · balance to 100%
ClassificationNot classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Physical stateLiquid. Clear, colourless to faintly yellow aqueous solution.
Storage2–8 °C, protected from light; do not freeze
HandlingHandle the device as a sharp: never recap or reuse needles, keep fingers away from the needle, and discard used devices into a rigid sharps container. Avoid splashes to eyes and skin. Wash hands after handling.
First aidEyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
DisposalChemical waste through a licensed contractor; do not pour down the drain. Used pens and needles go into a sharps container.
TransportNot regulated as a dangerous good (DOT / IATA / IMDG).

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Peptide Research Articles

An educational infographic detailing the primary health benefits of 5-Amino-1MQ, listing key advantages such as NNMT enzyme inhibition, enhanced cellular metabolism, targeted fat loss, and muscle tissue preservation.

5-Amino-1MQ: What It Is, Capsules vs Vial and Research

What 5-amino-1MQ is, how NNMT inhibition is thought to drive fat metabolism and NAD+ support, what the (largely preclinical) research actually shows, the honest limitations, and how to source research-grade material.

SR9011 research library featured image: designed at Scripps in 2012 to set the body clock, injected into mice because it does not survive the gut, and named on the WADA list before anyone measured it in a person

SR9011 and SR9009: What a Rev-erb Agonist Does in Mice, What It Does Off-Target, and Why No Human Has Been Dosed

SR9011 and its sibling SR9009 (stenabolic) were built at Scripps in 2012 as tools to press harder on the brake in the body’s circadian clock. Injected into mice they shifted clock genes, raised energy expenditure and cut fat and lipids in obese animals, and in 2018 they killed cancer cells while sparing normal ones. They do not survive the gut, the mice lost their normal activity rhythm, SR9009 was shown in 2019 to act on cells with no Rev-erb receptor at all, and no human has ever been dosed in a published study. This reference sets out the mechanism, the animal record, the off-target problem and the WADA history, and how to tell the two compounds apart on a certificate.

24-hour support icon
24/7 Online support

support@prymalab.net info@prymalab.net

Quality guarantee badge icon
7-day returns

Unopened, sealed products can be returned within 7 days of delivery. See our Return Policy.

Shipping truck icon
Free US shipping

Free standard shipping on US orders over $100.